S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Rockwell Medical Stock Forecast, Price & News

-0.01 (-0.78%)
(As of 07/1/2022 03:26 PM ET)
Today's Range
50-Day Range
52-Week Range
645 shs
Average Volume
108,678 shs
Market Capitalization
$12.01 million
P/E Ratio
Dividend Yield
Price Target

Rockwell Medical MarketRank™ Forecast

Analyst Rating
3.00 Rating Score
2,478.1% Upside
$33.00 Price Target
Short Interest
3.49% of Float Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
1.24mentions of Rockwell Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($3.56) to ($3.92) Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.97 out of 5 stars

Medical Sector

532nd out of 1,428 stocks

Pharmaceutical Preparations Industry

252nd out of 680 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive RMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter.

Rockwell Medical logo

About Rockwell Medical (NASDAQ:RMTI) Stock

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

RMTI Stock News Headlines

Rockwell Medical drops 14% as CEO departs
Rockwell Medical launches $15M at-market offering
Rockwell Medical Reports Q1 Loss of $0.84/sh
Rockwell Medical Q4 2021 Earnings Preview
Preview: Rockwell Medical's Earnings
See More Headlines

Industry, Sector and Symbol

Pharmaceutical preparations
Health Care Equipment
Current Symbol
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
1 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$61.93 million
Book Value
$0.30 per share


Free Float
Market Cap
$12.01 million

Social Links

Rockwell Medical Frequently Asked Questions

Should I buy or sell Rockwell Medical stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Rockwell Medical stock.
View analyst ratings for Rockwell Medical
or view top-rated stocks.

What is Rockwell Medical's stock price forecast for 2022?

1 Wall Street analysts have issued 12 month price objectives for Rockwell Medical's stock. Their RMTI stock forecasts range from $33.00 to $33.00. On average, they anticipate Rockwell Medical's share price to reach $33.00 in the next year. This suggests a possible upside of 2,478.1% from the stock's current price.
View analysts' price targets for Rockwell Medical
or view top-rated stocks among Wall Street analysts.

How has Rockwell Medical's stock price performed in 2022?

Rockwell Medical's stock was trading at $4.51 on January 1st, 2022. Since then, RMTI stock has decreased by 71.6% and is now trading at $1.28.
View the best growth stocks for 2022 here

When is Rockwell Medical's next earnings date?

Rockwell Medical is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022.
View our earnings forecast for Rockwell Medical

How were Rockwell Medical's earnings last quarter?

Rockwell Medical, Inc. (NASDAQ:RMTI) posted its quarterly earnings data on Thursday, May, 19th. The company reported ($0.84) earnings per share for the quarter, topping analysts' consensus estimates of ($0.99) by $0.15. The business earned $16.12 million during the quarter, compared to the consensus estimate of $18.80 million. Rockwell Medical had a negative net margin of 51.27% and a negative trailing twelve-month return on equity of 474.88%. During the same period in the prior year, the firm earned ($0.08) EPS.
View Rockwell Medical's earnings history

When did Rockwell Medical's stock split? How did Rockwell Medical's stock split work?

Rockwell Medical shares reverse split before market open on Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 13th 2022. An investor that had 100 shares of Rockwell Medical stock prior to the reverse split would have 9 shares after the split.

Who are Rockwell Medical's key executives?

Rockwell Medical's management team includes the following people:
  • Dr. Russell H. Ellison M.D., M.Sc., MSc., Pres, CEO & Director (Age 74, Pay $501.13k)
  • Mr. Russell L. Skibsted M.B.A., Exec. VP, CFO & Chief Bus. Officer (Age 63, Pay $598.92k)
  • Mr. Michael DeYoung, VP of Operations
  • Mr. Paul E. McGarry, VP, Corp. Controller & Principal Accounting Officer (Age 54)
  • Ms. Megan C. Timmins, Sr. VP, Gen. Counsel & Corp. Sec. (Age 49)
  • Mr. James A. McCarthy, Sr. VP of Bus. & Corp. Devel.
  • Mr. Timothy T. Chole, Sr. VP of Sales & Marketing
  • Dr. Marc L. Hoffman, Chief Medical Officer (Age 61)
  • Mr. David J. Kull, Sec. (Age 54)
  • Mr. Jason Finkelstein, Investor Relations Representative

What is Robert L. Chioini's approval rating as Rockwell Medical's CEO?

6 employees have rated Rockwell Medical CEO Robert L. Chioini on Glassdoor.com. Robert L. Chioini has an approval rating of 22% among Rockwell Medical's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Rockwell Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seagen (SGEN), Geron (GERN), OPKO Health (OPK), Amarin (AMRN), Gilead Sciences (GILD), ImmunoGen (IMGN), Sorrento Therapeutics (SRNE) and VBI Vaccines (VBIV).

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

How do I buy shares of Rockwell Medical?

Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rockwell Medical's stock price today?

One share of RMTI stock can currently be purchased for approximately $1.28.

How much money does Rockwell Medical make?

Rockwell Medical (NASDAQ:RMTI) has a market capitalization of $12.01 million and generates $61.93 million in revenue each year.

How many employees does Rockwell Medical have?

Rockwell Medical employs 300 workers across the globe.

When was Rockwell Medical founded?

Rockwell Medical was founded in 1995.

How can I contact Rockwell Medical?

Rockwell Medical's mailing address is 411 HACKENSACK AVENUE SUITE 501, HACKENSACK NJ, 07601. The official website for Rockwell Medical is www.rockwellmed.com. The company can be reached via phone at (248) 960-9009, via email at invest@rockwellmed.com, or via fax at 248-960-9119.

This page (NASDAQ:RMTI) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.